These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8506764)

  • 21. Messenger RNA encoding the insulin-like growth factors and their binding proteins, in women with fibroids, pretreated with luteinizing hormone-releasing hormone agonists.
    Vollenhoven BJ; Herington AC; Healy DL
    Hum Reprod; 1994 Feb; 9(2):214-9. PubMed ID: 7517948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of fibroids on reproductive function.
    Khaund A; Lumsden MA
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):749-60. PubMed ID: 18547868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact and management of fibroids for fertility: an evidence-based approach.
    Guo XC; Segars JH
    Obstet Gynecol Clin North Am; 2012 Dec; 39(4):521-33. PubMed ID: 23182558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids?
    Tropeano G; Romano D; Mascilini F; Gaglione R; Amoroso S; Scambia G
    J Obstet Gynaecol Res; 2012 Apr; 38(4):733-6. PubMed ID: 22413857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
    Friedman AJ; Lobel SM; Rein MS; Barbieri RL
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of uterine fibroids.
    al-Taher H; Farquharson RG
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):133-6. PubMed ID: 8353665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Hysteroscopic and Robot-assisted Laparoscopic Myomectomy in the Setting of Infertility.
    Lewis EI; Gargiulo AR
    Clin Obstet Gynecol; 2016 Mar; 59(1):53-65. PubMed ID: 26630075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports.
    Tinelli A; Hurst BS; Hudelist G; Tsin DA; Stark M; Mettler L; Guido M; Malvasi A
    Hum Reprod; 2012 Feb; 27(2):427-35. PubMed ID: 22095838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy.
    Guarnaccia MM; Rein MS
    Clin Obstet Gynecol; 2001 Jun; 44(2):385-400. PubMed ID: 11345000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
    West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
    Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroids and infertility: a systematic review of the evidence.
    Pritts EA
    Obstet Gynecol Surv; 2001 Aug; 56(8):483-91. PubMed ID: 11496160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR imaging evaluation of fibroid clearance following open myomectomy for massive/multiple symptomatic fibroids.
    Wijesekera NT; Mauri G; Gupta S; Belli AM; Manyonda IT
    Arch Gynecol Obstet; 2012 Nov; 286(5):1165-71. PubMed ID: 22710951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infertility and uterine fibroids.
    Zepiridis LI; Grimbizis GF; Tarlatzis BC
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():66-73. PubMed ID: 26856931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
    Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F
    Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of LHRH analogue action in uterine fibroids.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine fibroids: relationships to reproduction.
    Vilos GA
    Minerva Ginecol; 2003 Oct; 55(5):417-23. PubMed ID: 14581884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying patients who can improve fertility with myomectomy.
    Samejima T; Koga K; Nakae H; Wada-Hiraike O; Fujimoto A; Fujii T; Osuga Y
    Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():28-32. PubMed ID: 25522114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the position of fibroids on fertility.
    Casini ML; Rossi F; Agostini R; Unfer V
    Gynecol Endocrinol; 2006 Feb; 22(2):106-9. PubMed ID: 16603437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Sharma M; Buck L; Mastrogamvrakis G; Kontos K; Magos A; Taylor A
    BJOG; 2003 Jul; 110(7):712; author reply 712-3. PubMed ID: 12842071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.